Form 4 for ORMP ORAMED PHARMACEUTICALS INC.
Accepted 2024-06-10 00:00:00 ET · period of report 2024-06-06 · accession 0001213900-24-051336 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-10 | 2024-06-06 | ORMP | Reznick Yehuda | Dir | A - Grant | — | +760 | 30.6K | +3% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-06 | A | A | 760 | — | 30,560 | D | — | — | (F1) Represents a grant of 760 Restricted Stock Units ("RSUs") that will vest in two equal installments on October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. |